014604196	014604196	CD	B-NP	O
|	|	NNP	I-NP	O
WCH	WCH	NNP	I-NP	O
|	|	VBD	B-VP	O
66153194	66153194	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1254797	1254797	CD	B-NP	O
|	|	CC	I-NP	O
10/4/2006	10/4/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/14/2006	10/14/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
BENZEE	BENZEE	NNP	B-NP	O
,	,	,	O	O
IVORY	IVORY	NNP	B-NP	O
MD	MD	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
10/14/2006	10/14/2006	CD	B-NP	O
DATE	DATE	NN	I-NP	O
OF	OF	IN	B-PP	O
INTERIM	INTERIM	JJ	B-NP	O
DICTATION	DICTATION	NN	I-NP	O
:	:	:	O	O
1/7/2006	1/7/2006	CD	B-NP	O
PRIMARY	PRIMARY	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Left	Leave	VBN	B-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
distal	distal	JJ	I-NP	O
tibia	tibia	NN	I-NP	O
fracture	fracture	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52-year-old	52-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
non	non	JJ	B-NP	O
ST	ST	JJ	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
stenting	stente	VBG	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypertension	hypertension	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
on	on	IN	B-PP	O
10/14/2006	10/14/2006	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
intertrochanteric	intertrochanteric	JJ	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
after	after	IN	B-PP	O
fall	fall	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
states	state	VBZ	B-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
walking	walk	VBG	I-VP	O
outside	outside	IN	B-PP	O
his	his	PRP$	B-NP	O
house	house	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
deck	deck	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
dog	dog	NN	I-NP	O
and	and	CC	O	O
tripped	trip	VBD	B-VP	O
and	and	CC	O	O
fell	fall	VBD	B-VP	O
on	on	RP	B-PRT	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
preceding	preceding	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

Imaging	Imaging	NN	B-NP	O
upon	upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
comminuted	comminuted	JJ	I-NP	O
intertrochanteric	intertrochanteric	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
femur	femur	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
refracture	refracture	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
alignment	alignment	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
nonhealing	nonhealing	JJ	I-NP	O
distal	distal	JJ	I-NP	O
tib-fib	tib-fib	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
non-ST	non-ST	JJ	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
stenting	stenting	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
most	most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
for	for	IN	B-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
living-related	living-related	JJ	B-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
rejection	rejection	NN	I-NP	O
and	and	CC	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
is	be	VBZ	B-VP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
since	since	IN	B-SBAR	O
age	age	NN	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
PEA	PEA	NN	B-NP	O
arrest	arrest	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypercalcemia	hypercalcemia	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
open	open	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
and	and	CC	O	O
internal	internal	JJ	B-NP	O
fixation	fixation	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
for	for	IN	B-PP	O
nonunion	nonunion	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tibial	tibial	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
1334	1334	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
enalapril	enalapril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
32	32	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
levothyroxine	levothyroxine	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
one	one	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
Caltrate	Caltrate	NN	B-NP	O
plus	plus	CC	O	O
vitamin	vitamin	NN	B-NP	O
D	D	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	B-protein
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
sevelamer	sevelamer	NN	B-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Toprol	Toprol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NN	B-NP	B-protein
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

Former	Former	JJ	B-NP	O
smoker	smoker	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
97.7	97.7	CD	I-NP	O
,	,	,	I-NP	O
73	73	CD	I-NP	O
,	,	,	I-NP	O
135/68	135/68	CD	I-NP	O
,	,	,	I-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L.	L.	NNP	I-NP	O
Generally	Generally	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
anteriorly	anteriorly	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
extremities	extremity	NNS	I-NP	O
show	show	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
bandaged	bandage	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
DPs	DP	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
upon	upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
73	73	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
but	but	CC	O	O
isolated	isolate	VBN	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
III	III	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
7/14/2006	7/14/2006	CD	B-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
,	,	,	O	O
QRS	QRS	NNS	B-NP	B-protein
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
duration	duration	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
K	K	NN	I-NP	I-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
6.7	6.7	CD	B-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
6.1	6.1	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
on	on	IN	B-PP	O
10/14/2006	10/14/2006	CD	B-NP	O
was	be	VBD	B-VP	O
13.1	13.1	CD	B-NP	O
,	,	,	I-NP	O
43.9	43.9	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
309	309	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
CBC	CBC	NNP	I-NP	B-cell_type
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1	1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
impression	impression	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
53-year-old	53-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
recent	recent	JJ	B-NP	O
revascularization	revascularization	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
R	R	NN	I-NP	O
distal	distal	JJ	I-NP	O
tib/fib	tib/fib	NN	I-NP	O
fx	fx	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
three	three	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
suffered	suffer	VBD	B-VP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
requiring	require	VBG	B-VP	O
urgent	urgent	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EF	EF	NN	I-NP	B-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
single-vessel	single-vessel	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
involving	involve	VBG	B-VP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
restenosis	restenosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
schedule	schedule	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
until	until	IN	B-PP	O
10/16/2006	10/16/2006	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
open	open	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
and	and	CC	O	O
internal	internal	JJ	B-NP	O
fixation	fixation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
intertrochanteric	intertrochanteric	JJ	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
summary	summary	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
refer	refer	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
injury	injury	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
conservatively	conservatively	RB	B-ADVP	O
initially	initially	RB	I-ADVP	O
with	with	IN	B-PP	O
splinting	splinting	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/20/2006	10/20/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
revision	revision	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
fixation	fixation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
deep	deep	JJ	B-NP	O
hardware	hardware	NN	I-NP	O
and	and	CC	O	O
intramedullary	intramedullary	JJ	B-NP	O
rodding	rodding	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
distal	distal	JJ	I-NP	O
tibia	tibia	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
VAC	VAC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/17/2006	9/17/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
VAC	VAC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
suction	suction	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
oozing	ooze	VBG	I-VP	O
steadily	steadily	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
eventual	eventual	JJ	I-NP	O
EBL	EBL	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
L	L	NN	I-NP	O
within	within	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
also	also	RB	B-ADVP	O
droped	drop	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
80s	80s	CD	I-NP	O
to	to	TO	I-NP	O
90s	90s	CD	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Legacy	Legacy	NNP	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
7D	7D	NN	I-NP	O
ICU	ICU	NN	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
open	open	JJ	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
relative	relative	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
hemorrhage	hemorrhage	NN	B-NP	O
shock	shock	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lovenox	Lovenox	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
combination	combination	NN	I-NP	O
certainly	certainly	RB	B-ADVP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
oozing	ooze	VBG	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
VAC	VAC	NN	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
several	several	JJ	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
after	after	IN	B-SBAR	O
hematocrit	hematocrit	NN	B-NP	O
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
28	28	CD	B-NP	O
to	to	TO	B-PP	O
19	19	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
within	within	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
service	service	NN	I-NP	O
continued	continue	VBD	B-VP	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
open	open	JJ	B-ADJP	O
inferiorly	inferiorly	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/6/2006	1/6/2006	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Aland	Aland	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
consulted	consult	VBN	I-VP	O
regarding	regard	VBG	I-VP	O
the	the	DT	B-NP	O
safety	safety	NN	I-NP	O
of	of	IN	B-PP	O
discontinuing	discontinue	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and/or	and/or	CC	O	O
Lovenox	Lovenox	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
taking	take	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
service	service	NN	I-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
Plavix	Plavix	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
safely	safely	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
but	but	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
postoperatively	postoperatively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
with	with	IN	B-PP	O
daily	daily	JJ	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
until	until	IN	B-PP	O
10/10/2006	10/10/2006	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
medialization	medialization	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Plavix	Plavix	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
6/18/2006	6/18/2006	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
one	one	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
9/25/2006	9/25/2006	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
ooze	ooze	VB	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
injection	injection	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
and	and	CC	O	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
wound	wound	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
time	time	NN	I-NP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
systems	system	NNS	B-NP	O
:	:	:	O	O
Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
receiving	receive	VBG	I-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
methadone	methadone	NN	B-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Dilaudid	Dilaudid	NN	B-NP	O
0.2	0.2	CD	I-NP	O
to	to	TO	I-NP	O
0.4	0.4	CD	I-NP	O
q.	q.	NN	I-NP	O
3h	3h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
although	although	IN	B-SBAR	O
his	his	PRP$	B-NP	O
systolics	systolic	NNS	I-NP	O
often	often	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
prolonged	prolong	VBN	I-VP	O
QT	QT	NN	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
400	400	CD	B-NP	O
to	to	TO	B-PP	O
500	500	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
frequent	frequent	JJ	I-NP	O
PVCs	PVC	NNS	I-NP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
requiring	require	VBG	B-VP	O
readmission	readmission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
.	.	.	O	O

Respiratory	Respiratory	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
since	since	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
decreased	decrease	VBN	I-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
recommending	recommend	VBG	B-VP	O
frappes	frappe	NNS	B-NP	O
and	and	CC	O	O
Boost	Boost	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
minimally	minimally	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
on	on	IN	B-PP	O
PhosLo	PhosLo	NNP	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
,	,	,	O	O
Caltrate	Caltrate	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sevelamer	sevelamer	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
makes	make	VBZ	B-VP	O
minimal	minimal	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
sessions	session	NNS	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Saturday	Saturday	NNP	B-NP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
current	current	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
8.6	8.6	CD	B-NP	O
.	.	.	O	O

Hematologically	Hematologically	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
his	his	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
requiring	require	VBG	I-VP	O
ICU	ICU	NN	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
regarding	regard	VBG	B-VP	O
over-anticoagulation	over-anticoagulation	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
preoperatively	preoperatively	RB	B-ADVP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
.	.	.	O	O

Subcutaneous	Subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
on	on	IN	B-PP	O
postop	postop	NN	B-NP	O
day	day	NN	I-NP	O
two	two	CD	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
oozing	ooze	VBG	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
injection	injection	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	O	O
the	the	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
31.6	31.6	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
wise	wise	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
and	and	CC	I-NP	O
NovoLog	NovoLog	NN	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
titrated	titrate	VBN	I-VP	O
per	per	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wound	wound	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
granulating	granulate	VBG	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
ecchymosis	ecchymosis	NN	B-NP	O
and	and	CC	I-NP	O
skin	skin	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
and	and	CC	I-VP	O
darkening	darken	VBG	I-VP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
receiving	receive	VBG	I-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
surgery	surgery	NN	I-NP	O
incisions	incision	NNS	I-NP	O
are	be	VBP	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-2787555	7-2787555	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
EXTON	EXTON	NNP	B-NP	O
,	,	,	O	O
RICKY	RICKY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BECKMEYER	BECKMEYER	NNP	B-NP	O
,	,	,	O	O
MURRAY	MURRAY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5723597	5723597	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/23/06	1/23/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/23/06	1/23/06	CD	B-NP	O

